Regulation & Compliance

As Pasithea Therapeutics heads to a key investor conference, all eyes are on its lead drug, PAS-004, and its potential to treat rare and complex diseases.

Zefiro Methane founder accuses the board of entrenchment tactics, setting the stage for a critical BCSC hearing that will shape the company's future.

A new therapy for a rare brain cancer is one step closer to patients after the FDA accepted tirabrutinib for accelerated review, offering hope where few options exist.

Landmark Phase 3 trial results show psilocybin offers rapid, lasting relief for severe depression, pushing psychedelic medicine closer to the mainstream.

As BRC Inc. preps its 2025 earnings report, can its new energy drink line and veteran mission overcome inflation, lawsuits, and declining margins?

With a new $12M investment, Lightworks aims to help large firms move AI from pilot to production by solving the critical challenges of safety and compliance.

A Swedish biotech and Belgian university secure major EU funding to advance a first-in-class drug against glioblastoma, a notoriously deadly brain tumor.

After a soft 2025, Graphic Packaging's CEO faces investors. With the stock lagging, all eyes are on whether its green strategy can deliver growth.

Beyond chatbots, agentic AI is creating autonomous service systems. A new playbook details how this transforms ROI and the role of the human agent.

Marine Bancorp's merger with ELGA Credit Union is nearly final, part of a national trend. What does this mean for customers and the banking landscape?

Virtual IT Group appoints ex-Optus leader Maurice McCarthy as CEO, signaling a strategic push to secure the mid-market amid rising cyber and AI pressures.

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

After a costly regulatory exit, crypto giant Nexo plans a 2026 U.S. return, partnering with Bakkt in a bid to redefine compliant digital finance.

A lawsuit claims a specialized pediatric daycare failed to protect a vulnerable child, leading to unexplained injuries and a state investigation.

A new Swiss prop firm enters the market, promising real funded accounts and clear rules to address widespread trader distrust in the industry.

Passwork's latest update introduces new restrictions on personal password vaults, aiming to curb shadow IT and bolster enterprise data protection.

Despite public speculation, a new survey shows Capitol Hill aides, especially Republicans, are deeply skeptical of a Trump 2028 bid, citing constitutional barriers.

Linkhome's new AI promises to streamline home buying, but its debut raises questions about market disruption, ethics, and the future of real estate.

A new report reveals a crisis in fraud prevention, as sophisticated AI-driven scams outpace corporate defenses and put customer experience at risk.

Paris-based Doctrine acquires Spain's Maite.ai, accelerating its M&A strategy to build a sovereign European alternative to global tech giants.